PARSCHAUER KARAH HERDMAN 1677455 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-02 | 2024-01-30 | 2024-01-30 | 4 | Parschauer Karah Herdman | DIRECTOR | dsp | 11931.0 | 27.63 | 2.09 | 13.14 | Direct | Common Stock | EVOLUS, INC. | code S | 31243.0 | 57.15 (EOLS) |
| 2024-02-09 | 2024-02-07 | 2024-02-07 | 4 | Parschauer Karah Herdman | DIRECTOR | acq | 6464.0 | 17.14 | 1.13 | 0.0 | Direct | Common Stock | EVOLUS, INC. | code A | 37707.0 | 57.15 (EOLS) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Parschauer Karah Herdman | EVP AND CHIEF LEGAL OFFICER | dsp | 3756.0 | 5.28 | 0.46 | 53.76 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code S | 67340.0 | 82.11 (RARE) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Parschauer Karah Herdman | EVP AND CHIEF LEGAL OFFICER | acq | 18757.0 | 26.52 | 2.28 | 0.0 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code A | 70739.0
|
82.11 (RARE) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-12 | 2023-06-09 | 2023-06-09 | 4 | Parschauer Karah Herdman | DIRECTOR | acq | 29532.0 | 100.0 | 4.42 | 7.12 | Direct | Stock Option (Right To Buy) | TENAYA THERAPEUTICS, INC. | code A | 29532.0 | 66.87 (TNYA) |
| 2024-02-09 | 2024-02-07 | 2024-02-07 | 4 | Parschauer Karah Herdman | DIRECTOR | acq | 9377.0 | 100.0 | 1.64 | 13.15 | Direct | Stock Option (Right To Buy) | EVOLUS, INC. | code A | 9377.0 | 57.15 (EOLS) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Parschauer Karah Herdman | EVP AND CHIEF LEGAL OFFICER | acq | 31400.0 | 100.0 | 3.82 | 53.69 | Direct | Stock Option (Right To Buy) | ULTRAGENYX PHARMACEUTICAL INC. | code A | 31400.0 | 82.11 (RARE) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)